Noetik CEO and co-founder Ron Alfa, M.D., Ph.D., said the licensing of human foundation models is “a new paradigm in biotech.” With the GSK deal validating the paradigm, in Alfa’s view, Noetik ...
His job is to reimagine the future of drugmaking using that similarly trendy branch of computer science, artificial ...
Molecular discoveries may help improve treatments for labor and pain. When labor starts, the uterus must produce steady, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback